Literature DB >> 12692052

Cell migration: a novel aspect of pancreatic stellate cell biology.

P A Phillips1, M J Wu, R K Kumar, E Doherty, J A McCarroll, S Park, R C Pirola, J S Wilson, M V Apte.   

Abstract

BACKGROUND: Pancreatic stellate cells (PSCs), implicated as key mediators of pancreatic fibrogenesis, are found in increased numbers in areas of pancreatic injury. This increase in PSC number may be due to increased local proliferation and/or migration of these cells from adjacent areas. The ability of PSCs to proliferate has been well established but their potential for migration has not been examined. AIMS: Therefore, the aims of this study were to determine whether cultured rat PSCs have the capacity to migrate and, if so, to characterise this migratory capacity with respect to the influence of basement membrane components and the effect of platelet derived growth factor (PDGF, a known stimulant for migration of other cell types).
METHODS: Migration of freshly isolated (quiescent) and culture activated (passaged) rat PSCs was assessed across uncoated or Matrigel (a basement membrane-like substance) coated porous membranes (pore size 8 micro m) in the presence or absence of PDGF (10 and 20 ng/ml) in the culture medium. A checkerboard assay was performed to assess whether the effect of PDGF on PSC migration was chemotactic or chemokinetic.
RESULTS: Cell migration was observed with both freshly isolated and passaged PSCs. However, compared with passaged (culture activated) cells, migration of freshly isolated cells was delayed, occurring only at or after 48 hours of incubation when the cells displayed an activated phenotype. PSC migration through Matrigel coated membranes was delayed but not prevented by basement membrane components. PSC migration was increased by PDGF and this effect was predominantly chemotactic (that is, in the direction of a positive concentration gradient).
CONCLUSIONS: (i) PSCs have the capacity to migrate. (ii) Activation of PSCs appears to be a prerequisite for migration. (iii) PDGF stimulates PSC migration and this effect is predominantly chemotactic. IMPLICATION: Chemotactic factors released during pancreatic injury may stimulate the migration of PSCs through surrounding basement membrane towards affected areas of the gland.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692052      PMCID: PMC1773645          DOI: 10.1136/gut.52.5.677

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

Review 1.  Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

Authors:  S L Friedman
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells.

Authors:  E Schneider; A Schmid-Kotsas; J Zhao; H Weidenbach; R M Schmid; A Menke; G Adler; J Waltenberger; A Grünert; M G Bachem
Journal:  Am J Physiol Cell Physiol       Date:  2001-08       Impact factor: 4.249

3.  Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis.

Authors:  P Mews; P Phillips; R Fahmy; M Korsten; R Pirola; J Wilson; M Apte
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

4.  Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.

Authors:  Fanny Wai-Tsing Shek; Robert Christopher Benyon; Fiona Mairi Walker; Peter Raymond McCrudden; Sylvia Lin Foon Pender; Elizabeth Jean Williams; Penelope Ann Johnson; Colin David Johnson; Adrian Calvin Bateman; David Roger Fine; John Peter Iredale
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells.

Authors:  G R Grotendorst; T Chang; H E Seppä; H K Kleinman; G R Martin
Journal:  J Cell Physiol       Date:  1982-11       Impact factor: 6.384

6.  Collagen type I synthesized by pancreatic periacinar stellate cells (PSC) co-localizes with lipid peroxidation-derived aldehydes in chronic alcoholic pancreatitis.

Authors:  A Casini; A Galli; P Pignalosa; L Frulloni; C Grappone; S Milani; P Pederzoli; G Cavallini; C Surrenti
Journal:  J Pathol       Date:  2000-09       Impact factor: 7.996

7.  Repetitive self-limited acute pancreatitis induces pancreatic fibrogenesis in the mouse.

Authors:  B A Neuschwander-Tetri; F R Burton; M E Presti; R S Britton; C G Janney; P R Garvin; E M Brunt; N J Galvin; J E Poulos
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

8.  Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-beta1 transgenic mouse model.

Authors:  R Vogelmann; D Ruf; M Wagner; G Adler; A Menke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-01       Impact factor: 4.052

9.  Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis.

Authors:  P S Haber; G W Keogh; M V Apte; C S Moran; N L Stewart; D H Crawford; R C Pirola; G W McCaughan; G A Ramm; J S Wilson
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

10.  Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.

Authors:  P A Phillips; J A McCarroll; S Park; M-J Wu; R Pirola; M Korsten; J S Wilson; M V Apte
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

View more
  32 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

Review 2.  Investigating the pathobiology of alcoholic pancreatitis.

Authors:  Stephen J Pandol; Aurelia Lugea; Olga A Mareninova; Duane Smoot; Fred S Gorelick; Anna S Gukovskaya; Ilya Gukovsky
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

3.  Analysis of the human pancreatic stellate cell secreted proteome.

Authors:  Angela Y Wehr; Emma E Furth; Vineet Sangar; Ian A Blair; Kenneth H Yu
Journal:  Pancreas       Date:  2011-05       Impact factor: 3.327

Review 4.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 5.  Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer.

Authors:  Han Liu; Qingyong Ma; Qinhong Xu; Jianjun Lei; Xuqi Li; Zheng Wang; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats.

Authors:  H F Zhao; T Ito; J Gibo; K Kawabe; T Oono; T Kaku; Y Arita; Q W Zhao; M Usui; K Egashira; H Nawata
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

Review 7.  Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.

Authors:  Pavan P Adiseshaiah; Rachael M Crist; Sara S Hook; Scott E McNeil
Journal:  Nat Rev Clin Oncol       Date:  2016-08-17       Impact factor: 66.675

8.  Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells.

Authors:  Wen-Bin Liu; Xing-Peng Wang; Kai Wu; Ru-Ling Zhang
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

9.  Epidermal growth factor receptor regulates pancreatic fibrosis.

Authors:  Stacy A Blaine; Kevin C Ray; Kevin M Branch; Pamela S Robinson; Robert H Whitehead; Anna L Means
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-16       Impact factor: 4.052

Review 10.  Alcoholic pancreatitis: pathogenesis, incidence and treatment with special reference to the associated pain.

Authors:  Raffaele Pezzilli; Antonio M Morselli-Labate
Journal:  Int J Environ Res Public Health       Date:  2009-11-04       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.